| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.BBAMCR.2005.09.001 |
| P698 | PubMed publication ID | 16226325 |
| P50 | author | Erich Gulbins | Q37611826 |
| P2093 | author name string | Volker Teichgräber | |
| Claudia R Bollinger | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ceramides | Q424213 |
| P304 | page(s) | 284-294 | |
| P577 | publication date | 2005-09-26 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Ceramide-enriched membrane domains | |
| P478 | volume | 1746 |
| Q55091228 | A Ceramide-Regulated Element in the Late Endosomal Protein LAPTM4B Controls Amino Acid Transporter Interaction. |
| Q40822247 | A Functionalized Sphingolipid Analogue for Studying Redistribution during Activation in Living T Cells |
| Q38660646 | A link between very long chain fatty acid elongation and mating-specific yeast cell cycle arrest |
| Q51743729 | A novel cisplatin mediated apoptosis pathway is associated with acid sphingomyelinase and FAS proapoptotic protein activation in ovarian cancer. |
| Q89857850 | A novel visible range FRET probe for monitoring acid sphingomyelinase activity in living cells |
| Q41993606 | Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver |
| Q84068693 | Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes |
| Q43345499 | Acid sphingomyelinase mediates 50-Hz magnetic field-induced EGF receptor clustering on lipid raft |
| Q45915435 | Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. |
| Q33624807 | Adjustment of Dysregulated Ceramide Metabolism in a Murine Model of Sepsis-Induced Cardiac Dysfunction |
| Q91710428 | Agonists that stimulate secretion promote the recruitment of CFTR into membrane lipid microdomains |
| Q36770915 | Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children |
| Q44950102 | Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells |
| Q89983533 | Behavior of 1-Deoxy-, 3-Deoxy- and N-Methyl-Ceramides in Skin Barrier Lipid Models |
| Q34058540 | Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. |
| Q90010368 | Ceramide Domains in Health and Disease: A Biophysical Perspective |
| Q57107532 | Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development |
| Q37344754 | Ceramide and mitochondria in ischemia/reperfusion |
| Q37970353 | Ceramide and mitochondria in ischemic brain injury. |
| Q57375110 | Ceramide and sphingomyelin species of fibroblasts and neurons in culture |
| Q36479732 | Ceramide channel: Structural basis for selective membrane targeting |
| Q40057653 | Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. |
| Q38021345 | Ceramide function in the brain: when a slight tilt is enough. |
| Q40112591 | Ceramide is a potent activator of plasma membrane Ca2+-ATPase from kidney-promixal tubule cells with protein kinase A as an intermediate |
| Q35918569 | Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells |
| Q36803735 | Ceramide signaling in cancer and stem cells |
| Q43054697 | Ceramide-domain formation and collapse in lipid rafts: membrane reorganization by an apoptotic lipid. |
| Q27350099 | Changes in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters. |
| Q53731153 | Characterization of Plasma Membrane Ceramides by Super-Resolution Microscopy. |
| Q57372464 | Cholesterol Precursors Stabilize Ordinary and Ceramide-rich Ordered Lipid Domains (Lipid Rafts) to Different Degrees |
| Q37137436 | Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol |
| Q42087759 | Cholesterol-rich fluid membranes solubilize ceramide domains: implications for the structure and dynamics of mammalian intracellular and plasma membranes. |
| Q41773170 | Cholesterol: A modulator of the phagocyte NADPH oxidase activity - A cell-free study |
| Q40137449 | Clostridium perfringens α-toxin impairs erythropoiesis by inhibition of erythroid differentiation |
| Q37149419 | Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction |
| Q36343192 | Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains |
| Q37952177 | Cytoskeletal dynamics: concepts in measles virus replication and immunomodulation |
| Q37343771 | Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis |
| Q28512474 | Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum |
| Q33693061 | Deregulation of sphingolipid metabolism in Alzheimer's disease |
| Q57375071 | Development and characterization of a novel anti-ceramide antibody |
| Q41887224 | Differential association of the Na+/H+ Exchanger Regulatory Factor (NHERF) family of adaptor proteins with the raft- and the non-raft brush border membrane fractions of NHE3. |
| Q39219658 | Disruption of lipid rafts interferes with the interaction of Toxoplasma gondii with macrophages and epithelial cells |
| Q39262040 | Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells. |
| Q35861726 | Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines |
| Q40095080 | Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts). |
| Q38345628 | Effect of osmotic shock and urea on phosphatidylserine scrambling in thrombocyte cell membranes |
| Q42425338 | Effects of ceramide on liquid-ordered domains investigated by simultaneous AFM and FCS |
| Q35627763 | Effects of sphingosine 2N- and 3O-methylation on palmitoyl ceramide properties in bilayer membranes. |
| Q46882249 | Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering |
| Q48148212 | Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. |
| Q36995176 | Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes |
| Q42271601 | Formation of ceramide/sphingomyelin gel domains in the presence of an unsaturated phospholipid: a quantitative multiprobe approach. |
| Q37118990 | Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury |
| Q33287507 | Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer |
| Q34001144 | HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies |
| Q37527686 | Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies |
| Q37727270 | Host-cell lipid rafts: a safe door for micro-organisms? |
| Q46530221 | IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons |
| Q34735669 | Impact of oxLDL on Cholesterol-Rich Membrane Rafts |
| Q33510915 | Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression |
| Q34451277 | Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice |
| Q38921081 | Interactions of meningococcal virulence factors with endothelial cells at the human blood-cerebrospinal fluid barrier and their role in pathogenicity |
| Q41933986 | Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium |
| Q42175059 | Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide |
| Q27490958 | Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus |
| Q36831121 | Lipid Phase Separation and Protein-Ganglioside Clustering in Supported Bilayers Are Induced by Photorelease of Ceramide |
| Q37918460 | Lipid metabolism modulation by the P2X7 receptor in the immune system and during the course of infection: new insights into the old view |
| Q37762334 | Lipid microdomains and the regulation of ion channel function |
| Q41974799 | Lipid raft composition modulates sphingomyelinase activity and ceramide-induced membrane physical alterations |
| Q37441286 | Lipid raft redox signaling platforms in vascular dysfunction: features and mechanisms |
| Q35101890 | Lipid raft redox signaling: molecular mechanisms in health and disease |
| Q37951442 | Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis |
| Q34178121 | Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice |
| Q37006808 | Lipidome analysis of rotavirus-infected cells confirms the close interaction of lipid droplets with viroplasms |
| Q37339704 | Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer |
| Q37402102 | Long term effects on human plasma lipoproteins of a formulation enriched in butter milk polar lipid |
| Q38918249 | Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells |
| Q52890205 | Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. |
| Q37157907 | Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells |
| Q34131213 | Lysosome-membrane fusion mediated superoxide production in hyperglycaemia-induced endothelial dysfunction |
| Q34156716 | Massive calcium-activated endocytosis without involvement of classical endocytic proteins |
| Q37727048 | Measles virus-induced immunosuppression: from effectors to mechanisms |
| Q24653084 | Membrane lipids: where they are and how they behave |
| Q34485791 | Membrane raft–lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin |
| Q33939529 | Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation |
| Q37058812 | Nanovehicular intracellular delivery systems |
| Q34734221 | Neutral sphingomyelinase in physiological and measles virus induced T cell suppression |
| Q37925819 | Nuclear sphingolipid metabolism |
| Q40165311 | Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts |
| Q24657751 | Phase behavior of lipid mixtures |
| Q38894687 | Phenotypic profiling of the human genome reveals gene products involved in plasma membrane targeting of SRC kinases |
| Q39356819 | Preparation, characterization, and surface immobilization of native vesicles obtained by mechanical extrusion of mammalian cells |
| Q48363266 | Promotion of endocytosis efficiency through an ATP-independent mechanism at rat calyx of Held terminals |
| Q46106695 | Rapid transmembrane diffusion of ceramide and dihydroceramide spin-labelled analogues in the liquid ordered phase. |
| Q58212931 | Regulation of K+ Channels by Cholesterol-Rich Membrane Domains in the Immune System |
| Q35891203 | Requirement of translocated lysosomal V1 H(+)-ATPase for activation of membrane acid sphingomyelinase and raft clustering in coronary endothelial cells. |
| Q36949766 | Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. |
| Q37609941 | Rice Stripe Virus Infection Alters mRNA Levels of Sphingolipid-Metabolizing Enzymes and Sphingolipids Content in Laodelphax striatellus |
| Q38679589 | Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies |
| Q37275486 | Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome |
| Q30541740 | Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis |
| Q91949633 | Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis |
| Q43263378 | Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice |
| Q36940332 | Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection |
| Q28476635 | Role of sphingomyelin synthase in controlling the antimicrobial activity of neutrophils against Cryptococcus neoformans |
| Q38560939 | Role of sphingomyelinases in neurological disorders |
| Q27488402 | Signal transduction pathways in liver and the influence of hepatitis C virus infection on their activities |
| Q37078030 | Smart drugs for smarter stem cells: making SENSe (sphingolipid-enhanced neural stem cells) of ceramide |
| Q37574812 | Sphingolipid Organization in the Plasma Membrane and the Mechanisms That Influence It |
| Q38332040 | Sphingolipids and mitochondrial apoptosis |
| Q38195691 | Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance |
| Q92923604 | Sphingomyelin Breakdown in T Cells: Role of Membrane Compartmentalization in T Cell Signaling and Interference by a Pathogen |
| Q28079694 | Structure and Nanomechanics of Model Membranes by Atomic Force Microscopy and Spectroscopy: Insights into the Role of Cholesterol and Sphingolipids |
| Q38887432 | Targeting ceramide metabolism in obesity |
| Q36641876 | Temporal aspects of the action of ASA404 (vadimezan; DMXAA) |
| Q54921400 | The Neutral Sphingomyelinase 2 Is Required to Polarize and Sustain T Cell Receptor Signaling. |
| Q38618873 | The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease |
| Q59042557 | The Role of the Actin Cytoskeleton and Lipid Rafts in the Localization and Function of the ABCC1 Transporter |
| Q27488727 | The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry |
| Q35653799 | The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma. |
| Q47332795 | The imaging FCS diffusion law in the presence of multiple diffusive modes |
| Q41780463 | The phenyltetraene lysophospholipid analog PTE-ET-18-OMe as a fluorescent anisotropy probe of liquid ordered membrane domains (lipid rafts) and ceramide-rich membrane domains. |
| Q36994532 | The way we view cellular (glyco)sphingolipids. |
| Q30493665 | Triggering role of acid sphingomyelinase in endothelial lysosome-membrane fusion and dysfunction in coronary arteries. |
| Q30487868 | Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors |
| Q39169754 | Unraveling the role of membrane microdomains during microbial infections. |
| Q34235479 | Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells |
| Q93048622 | Visualization of Ceramide-Associated Proteins in Ceramide-Rich Platforms Using a Cross-Linkable Ceramide Analog and Proximity Ligation Assays With Anti-ceramide Antibody |
| Q91857226 | Visualizing bioactive ceramides |
| Q37172903 | Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation |
| Q57788726 | Zika virus infection modulates the metabolomic profile of microglial cells |
| Q34577978 | n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer |
| Q34085637 | oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation |
| Q34292683 | α-TEA-induced death receptor dependent apoptosis involves activation of acid sphingomyelinase and elevated ceramide-enriched cell surface membranes |
Search more.